Early events in the pathogenesis of a murine transfer colitis

Pathobiology

Volumn 70, Issue 3, 2003, Pages 156-163

  Leithäuser, Frank ^a   Krajina, Tamara ^a   Trobonjaca, Zlatko ^a   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Adoptive transfer; Colitis; Inflammatory bowel disease

Indexed keywords

CD4 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANATOMY; CELL SPECIFICITY; CHRONIC DISEASE; COLITIS; CONFERENCE PAPER; CONGENIC STRAIN; DISABILITY; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; ENTERITIS; EXPERIMENTAL MOUSE; HISTOPATHOLOGY; HOST; IMMUNE RESPONSE; IMMUNOCOMPETENCE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECIPIENT; REGULATORY MECHANISM; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL TRANSPLANTATION; COLITIS, ULCERATIVE; COLON; DISEASE MODELS, ANIMAL; INTESTINAL MUCOSA; MICE; MICE, INBRED STRAINS;

ANIMALIA; MURINAE;

EID: 0037270053     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068148     Document Type: Conference Paper

References (35)

1. Zeitz M: Pathogenesis of inflammatory bowel disease. Digestion 1997;58(suppl 1):59-61.
2. Fiocchi C: Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998;115:182-205.
3. Hugot JP, Chamaillard M, Zouali H, et al: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
4. Ogura Y, Bonen DK, Inohara N, et al: A frame-shift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-606.
5. Cuthbert AP, Fisher SA, Mirza MM, et al: The contribution of NOD2 g mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-874.
6. Reimann J, Rudolphi A, Claesson MH: Novel experimental approaches in the study of the immunopathology in inflammatory bowel disease. J Mol Med 1995;73:133-140.
7. Blumberg RS, Saubermann LJ, Strober W: Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999;11:648-656.
8. Leach MW, Bean AG, Mauze S, Coffman RL, Powrie F: Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells. Am J Pathol 1996;148:1503-1515.
9. low CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994;179:589-600.
10. Morrissey PJ, Charrier K, Braddy S, Liggitt D, Watson JD: CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 1993;178:237-244.
11. Powrie F, Coffman RL: Inhibition of cell-mediated immunity by IL4 and IL10. Res Immunol 1993;144:639-643.
12. low CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994;179:589-600.
13. -/- hosts. J Immunol 2001;166:3804-3812.
14. high T cells to SCID recipients. J Immunol 1997;158:3464-3473.
15. Claesson MH, Bregenholt S, Bonhagen K, et al: Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J Immunol 1999;162:3702-3710.
16. Bonhagen K, Thoma S, Leithauser F, Moller P, Reimann J: A pancolitis resembling human ulcerative colitis (UC) is induced by CD4+ TCR alphabeta T cells of athymic origin in histocompatible severe combined immunodeficient (SCID) mice. Clin Exp Immunol 1998;112:443-452.
17. Bregenholt S, Reimann J, Claesson MH: Proliferation and apoptosis of lamina propria CD4+ T cells from scid mice with inflammatory bowel disease. Eur J Immunol 1998;28:3655-3663.
18. Kawachi S, Morise Z, Jennings SR, et al: Cytokine and adhesion molecule expression in SCID mice reconstituted with CD4+ T cells. Inflamm Bowel Dis 2000;6:171-180.
19. Brimnes J, Reimann J, Nissen M, Claesson M: Enteric bacterial antigens activate CD4(+) T cells from scid mice with inflammatory bowel disease. Eur J Immunol 2001;31:23-31.
20. Cong Y, Brandwein SL, McCabe RP, et al: CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med 1998;187:855-864.
21. Reimann J, Rudolphi A, Tscherning T, Claesson MH: Selective engraftment of memory CD4+ T cells with an unusual recirculation pattern and a diverse T cell receptor-V beta repertoire into scid mice. Eur J Immunol 1993;23:350-356.
22. Rudolphi A, Bonhagen K, Reimann J: Poly-clonal expansion of adoptively transferred CD4+ alpha beta T cells in the colonic lamina propria of scid mice with colitis. Eur J Immunol 1996;26:1156-1163.
23. Matsuda JL, Gapin L, Sydora BC, et al: Systemic activation and antigen-driven oligoclonal expansion of T cells in a mouse model of colitis. J Immunol 2000;164:2797-2806.
24. Takahashi I, Iijima H, Katashima R, Itakura M, Kiyono H: Clonal expansion of CD4+ TCRbetabeta+ T cells in TCR alpha-chain-deficient mice by gut-derived antigens. J Immunol 1999;162:1843-1850.
25. Bhan AK, Mizoguchi E, Smith RN, Mizoguchi A: Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev 1999;169:195-207.
26. Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL: A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med 1996;183:2669-2674.
27. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F: An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1004.
28. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-274.
29. Read S, Malmstrom V, Powrie F: Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302.
30. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK: Visualizing the generation of memory CD4 T cells in the whole body. Nature 2001;410:101-105.
31. Iqbal N, Oliver JR, Wagner FH, Lazenby AS, Elson CO, Weaver CT: T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis. J Exp Med 2002;195:71-84.
32. Iezzi G, Scheidegger D, Lanzavecchia A: Migration and function of antigen-primed nonpolarized T lymphocytes in vivo. J Exp Med 2001;193:987-993.
33. MacPherson GG, Jenkins CD, Stein MJ, Ed-wards C: Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence. J Immunol 1995;154:1317-1322.
34. Malmstrom V, Shipton D, Singh B, et al: CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J Immunol 2001;166:6972-6981.
35. Leithauser F, Trobonjaca Z, Moller P, Rei-mann J: Clustering of colonic lamina propria CD4(+) T cells to subepithelial dendritic cell aggregates precedes the development of colitis in a murine adoptive transfer model. Lab Invest 2001;81:1339-1349.